HIV

Laneshia Conner, Assistant Professor at the University of Kentucky, discusses gaps in HIV and AIDS prevention and why greater awareness and support for HIV risk in older adults is needed.

Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.

Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.